Empower Pharmacy markets itself as a well-meaning rival to Big Pharma — one that seeks to democratize medicine by making affordable, personalized drugs for patients who need them. As one of an ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

Compounding drugs prior to receipt of a valid prescription. Compounding drugs removed from the market for safety reasons. Compounding drugs that are essentially copies of commercially available ...

In 2022, California regulators penalized a Houston compounding pharmacy for sending hundreds of vitamin injections they said were made with low-quality ingredients into the state. In 2024, Iowa ...

Custom formulations of popular weight loss medications have surged in popularity due to the high costs of FDA-approved drugs.

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally blocking access to customized versions of their blockbuster weight-loss ...

As more people turn to blockbuster drugs like Wegovy to lose weight, some are choosing to skip the name-brand drugs and go online for less expensive alternatives made by specialized pharmacies. NPR ...

Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

The repeat problems at Houston-based Empower Pharmacy include inadequate quality testing and a failure to clean equipment.

Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging that the drug giants coordinated to stifle competition by hindering access ...